Phytoceuticalsis a life science company that develops or acquires intellectual property from natural product extracts, defines scientifically sound development protocols, manages product development and then seeks exit options for these developed medicines. The company’s current focus is to develop first-in-class solutions for major indications in dermatology.
Phytoceuticals’ lead product, 1 PRIMARY WOUND DRESSING®, is a primary wound product with comprehensive capabilities, targeting acute and chronic wounds in humans. In addition to the market for acute and chronic human wounds, formulations derived from 1 PRIMARY WOUND DRESSING® are targeting the markets for veterinary wounds (PHY020) and human inflammatory skin disorders (PHY030).
For further information, please visit: www.1wound.info
Swiss Television sends coverage about Phytoceuticals and 1 PRIMARY WOUND DRESSING®